|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.18 USD | -0.35% |
|
+4.19% | -4.38% |
| Apr. 25 | UBS Adjusts Sleep Number Price Target to $13 From $12, Maintains Neutral Rating | MT |
| Apr. 25 | Piper Sandler Adjusts Price Target on Sleep Number to $13 From $12, Keeps Neutral Rating | MT |
Sleep Number Corporation provided earnings outlook for the full-year 2023. For the period, the company expects diluted EPS outlook to a loss of up to $0.70 per share. The updated EPS outlook includes an estimated $10 million, or $0.35 per share, of restructuring charges to be recorded in the fourth quarter.
The 2023 outlook assumes net sales are down low double digits versus the prior year, with approximately 100 basis points of gross margin rate improvement year-over-year.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.38% | 317M | |
| -2.06% | 8.67B | |
| -4.20% | 3.79B | |
| +5.08% | 2.22B | |
| +6.69% | 1.8B | |
| -10.32% | 1.41B | |
| -27.03% | 1.18B | |
| +28.08% | 1.13B | |
| +4.35% | 928M | |
| -2.98% | 816M |
SLEEP NUMBER CORPORATION 
